fluorouracil has been researched along with thioctic acid in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (14.29) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (71.43) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Gao, M; Gao, X; Hua, H; Huang, X; Li, D; Li, H; Uchita, T; Wang, X; Xu, J; Xu, S | 1 |
| Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
| Rumack, BH; Smolinske, SC; Spoerke, DG; Wruk, KM | 1 |
| Abolhassani, M; Campion, F; Guais, A; Israël, M; Sanders, E; Schwartz, L; Steyaert, JM | 1 |
| Dörsam, B; Fahrer, J; Göder, A; Kaina, B; Seiwert, N | 1 |
| Conic, I; Damnjanovic, I; Kocic, G; Langerholc, T; Najman, S; Pesic, S; Stojanovic, D; Stojanovic, S; Veljkovic, A | 1 |
| Christmann, M; Diehl, E; Fahrer, J; Göder, A; Nagel, G; Neitzel, C; Rasenberger, B; Seiwert, N; Stroh, S; Weber, C | 1 |
7 other study(ies) available for fluorouracil and thioctic acid
| Article | Year |
|---|---|
Hydrogen sulfide donating ent-kaurane and spirolactone-type 6,7-seco-ent-kaurane derivatives: Design, synthesis and antiproliferative properties.
Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Diterpenes, Kaurane; Dose-Response Relationship, Drug; Drug Design; Drug Screening Assays, Antitumor; Humans; Hydrogen Sulfide; Membrane Potential, Mitochondrial; Molecular Structure; Spironolactone; Structure-Activity Relationship | 2019 |
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |
Infrequently used antidotes: indications and availability.
Topics: Aluminum Compounds; Aluminum Silicates; Aminopropionitrile; Antidotes; Antineoplastic Combined Chemotherapy Protocols; Antivenins; Arginine; Calcium; Carmustine; Ditiocarb; Doxorubicin; Ethanol; Ferrocyanides; Fluorouracil; Glycerides; Humans; Kaolin; Magnesium Compounds; Niacinamide; Penicillamine; Polyethylene Glycols; Silicates; Thioctic Acid | 1986 |
A combination of alpha lipoic acid and calcium hydroxycitrate is efficient against mouse cancer models: preliminary results.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; ATP Citrate (pro-S)-Lyase; Carcinoma, Lewis Lung; Cell Death; Cell Proliferation; Cisplatin; Citrates; Dose-Response Relationship, Drug; Energy Metabolism; Enzyme Inhibitors; Fluorouracil; HT29 Cells; Humans; Melanoma, Experimental; Mice; Mice, Inbred C3H; Mice, Inbred C57BL; Pyruvate Dehydrogenase (Lipoamide); Thioctic Acid; Time Factors; Tumor Burden; Urinary Bladder Neoplasms | 2010 |
Lipoic acid induces p53-independent cell death in colorectal cancer cells and potentiates the cytotoxicity of 5-fluorouracil.
Topics: Antimetabolites, Antineoplastic; Caco-2 Cells; Caspases; Cell Death; Cell Survival; Colorectal Neoplasms; Dose-Response Relationship, Drug; Drug Synergism; Fluorouracil; HCT116 Cells; Humans; Thioctic Acid; Tumor Suppressor Protein p53 | 2015 |
Chemopreventive potential of alpha lipoic acid in the treatment of colon and cervix cancer cell lines.
Topics: Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Caco-2 Cells; Cell Proliferation; Chemoprevention; Cisplatin; Colonic Neoplasms; Female; Fluorouracil; HeLa Cells; Humans; NF-kappa B; Thioctic Acid; Uterine Cervical Neoplasms | 2014 |
Lipoic Acid Synergizes with Antineoplastic Drugs in Colorectal Cancer by Targeting p53 for Proteasomal Degradation.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Cell Survival; Colorectal Neoplasms; Doxorubicin; Drug Synergism; Energy Metabolism; Fluorouracil; HCT116 Cells; Humans; Mutation; Proteasome Endopeptidase Complex; Proteolysis; Thioctic Acid; Tumor Suppressor Protein p53; Ubiquitination | 2019 |